David Beeson is a Senior Research Fellow at the Nuffield Department of Clinical Neuroscience, Oxford. He has made unique contributions to the molecular basis of neuromuscular junction disorders and has helped to transform the lives of many individuals with myasthenic syndromes. His sequencing of the human AChR epsilon subunit gene provided the critical information that led to the first discovery of a mutation explaining a congenital myasthenic syndrome. Subsequently his laboratory has led the international field identifying mutations in a remarkable series of neuromuscular junction genes. The success of this work resulted in the NHS commissioning a National Specialist Diagnostic and Advisory Service for congenital myasthenic syndromes led from Oxford.
FellowBack to directory listing
Professor David Beeson FMedSci
Professor in Molecular Neuroscience
Nuffield Department of Clinical Neuroscience
University of Oxford
The clinical genetics and molecular neuroscience that underlies disorders of the neuromuscular synapseSection committee elected by
Neuroscience (including neurology and neurosurgery), physiology, pharmacological sciences